The last fighter of the pandemic: Novavax Covid-19 vaccine is expected to be approved soon – Health News

In a study conducted on 15 thousand people in the UK, it was revealed that the Novavax vaccine was 89 percent effective in preventing Covid-19. In clinical trials in which more than 15 thousand people between the ages of 18-84 participated, 27 percent of whom were over the age of 65, it was stated that the vaccine provided 100 percent protection against serious diseases, including hospitalization and death.

Based on the Phase 3 trial results, it was stated that the vaccine was 86 percent effective against the British variant B.1.1.7, while it was announced that it provided 96 percent protection against Covid-19 without the variant.

In a separate South African arm of the trial, where most of the Covid-19 cases were South African variants, the vaccine was reported to be 60 percent effective in people who do not have HIV.

Leave a Reply

Your email address will not be published. Required fields are marked *